Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mansfield

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cancer|February 3, 2018
Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014Naruhiko Ikoma, Janice N Cormier, Barry Feig, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2018
Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matchingNaruhiko Ikoma, Prajnan Das, Wayne Hofstetter, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonographyNaruhiko Ikoma, Jeffrey H Lee, Manoop S Bhutani, et al.
JAMA Network Open|May 4, 2026
Appendiceal Adenocarcinoma Cytoreduction Outcomes and Perioperative Serum Tumor Marker LevelsVinay K Pattalachinti, Ashlee Seldomridge, Abdelrahman Yousef, et al.
JAMA Network Open|June 1, 2023
Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover TrialJohn Paul Shen, Abdelrahman M Yousef, Fadl A Zeineddine, et al.
Annals of Surgical Oncology|October 7, 2025
Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-SurgPaula Marincola Smith, Koichi Tomita, Samuel Cass, et al.
Annals of Surgery|March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panelNatalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery|October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panelMatthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
Annals of Surgical Oncology|September 4, 2012
A RAND/UCLA appropriateness study of the management of familial gastric cancerMatthew Dixon, Rajini Seevaratnam, Debrah Wirtzfeld, et al.
BJS Open|April 15, 2026
Development and validation of a short version of the MD Anderson Symptom Inventory for upper gastrointestinal surgery (short-MDASI-UGI-Surg) for postoperative patient-reported outcome-based careTaisuke Imamura, Koichi Tomita, Paula Marincola Smith, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cancer|February 3, 2018
Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014Naruhiko Ikoma, Janice N Cormier, Barry Feig, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2018
Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matchingNaruhiko Ikoma, Prajnan Das, Wayne Hofstetter, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonographyNaruhiko Ikoma, Jeffrey H Lee, Manoop S Bhutani, et al.
JAMA Network Open|May 4, 2026
Appendiceal Adenocarcinoma Cytoreduction Outcomes and Perioperative Serum Tumor Marker LevelsVinay K Pattalachinti, Ashlee Seldomridge, Abdelrahman Yousef, et al.
JAMA Network Open|June 1, 2023
Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover TrialJohn Paul Shen, Abdelrahman M Yousef, Fadl A Zeineddine, et al.
Annals of Surgical Oncology|October 7, 2025
Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-SurgPaula Marincola Smith, Koichi Tomita, Samuel Cass, et al.
Annals of Surgery|March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panelNatalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery|October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panelMatthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
Annals of Surgical Oncology|September 4, 2012
A RAND/UCLA appropriateness study of the management of familial gastric cancerMatthew Dixon, Rajini Seevaratnam, Debrah Wirtzfeld, et al.
BJS Open|April 15, 2026
Development and validation of a short version of the MD Anderson Symptom Inventory for upper gastrointestinal surgery (short-MDASI-UGI-Surg) for postoperative patient-reported outcome-based careTaisuke Imamura, Koichi Tomita, Paula Marincola Smith, et al.
Pageof 9